sar425899 glp-1 glucagon dual agonist sanofi Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity Emerging incretin- and multi-agonist-based treatments
Pay in 4 interest-free payments of $5.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


























